Corpus Intelligence IC Memo — FRANKLIN WOODS COMMUNITY HOSPITAL 2026-04-26 03:50 UTC
IC Memo — FRANKLIN WOODS COMMUNITY HOSPITAL
Investment Committee Memorandum | TN | 80 beds | Grade C | EBITDA uplift $8.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FRANKLIN WOODS COMMUNITY HOSPITAL

CCN 440184 | WASHINGTON, TN | 80 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

FRANKLIN WOODS COMMUNITY HOSPITAL is a 80-bed suburban community hospital in WASHINGTON, TN with $110.3M in net patient revenue and a 18.7% operating margin. The hospital serves a payer mix of 18.8% Medicare, 11.1% Medicaid, and 70.1% commercial.

Thesis: Turnaround. Our ML models identify $8.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.7% to 26.1% (+736bps).

Net Revenue HCRIS$110.3M
Current EBITDA COMPUTED$20.6M
Operating Margin COMPUTED18.7%
Occupancy HCRIS86.4%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS18.5%
Distress Probability ML39.6%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
60
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 18.7% places it above the state median. Among 60 size-comparable peers (40-160 beds), the median margin is -0.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-160), prioritizing same-state peers. 60 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FRANKLIN WOODS COMMUNITY HOSPI (Target)TN80$110.3M18.7%
BLOUNT MEMORIAL HOSPITALTN145$326.0M-8.5%
METRO NASHVILLE GENERAL HOSPITTN114$287.4M48.9%
TRISTAR HENDERSONVILLE MEDICALTN129$208.6M41.5%
TRISTAR STONECREST MEDICAL CENTN115$190.0M39.5%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
SUMNER REGIONAL MEDICAL CENTERTN138$161.9M-2.7%
VANDERBILT WILSON COUNTY HOSPITN113$158.7M-7.1%
METHODIST MEDICAL CENTERTN157$153.6M-9.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$71K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.3M
Clean Claim Rate
$71K
Total EBITDA Uplift$8.1M
Current EBITDA$20.6M
+ RCM Uplift+$8.1M
Pro Forma EBITDA$28.7M
Current Margin18.7%
Pro Forma Margin26.1%
WC Released (1x)$4.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$31.7M$217.2M6.85x46.9%
Base (11x exit)10.0x11.0x$31.7M$249.2M7.86x51.0%
Bull Case9.0x11.0x$28.5M$286.3M10.03x58.6%
Bull (12x exit)9.0x12.0x$28.5M$320.8M11.24x62.2%
Bear Case11.0x10.0x$34.9M$166.3M4.77x36.7%
Bear (11x exit)11.0x11.0x$34.9M$194.3M5.57x41.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 60 hospitals with 40-160 beds
  • Same-state prioritization (n=61)
  • Comp margins: P25=-10.8% / P50=-0.5% / P75=12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.